ERIN COOLEY: Open Payments
NPI 1730671538 · MERIDIAN, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$530 in 31 payments from 10 companies in 2025. Trend: 2023 $746 · 2024 $859 · 2025 $530
Food & beverage: $530
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 10 | $147 |
| PFIZER INC. | 4 | $87 |
| Lilly USA, LLC | 5 | $76 |
| Amgen Inc. | 3 | $52 |
| AstraZeneca Pharmaceuticals LP | 3 | $47 |
| Corcept Therapeutics | 2 | $41 |
| Lundbeck LLC | 1 | $27 |
| Averitas Pharma Inc. | 1 | $20 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $17 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $15 |
Products named: QULIPTA, MOUNJARO, EVENITY, FARXIGA, Korlym, NURTEC ODT, UBRELVY, REXULTI.
Industry payments across MS — which companies pay providers there.
